FIELD: medicine.
SUBSTANCE: group of invention refers to a method for testing graft versus host reaction involving measuring the CCL8 protein level in a sample taken from an individual as a diagnostic or control criteria of the course of graft versus host reaction, as well as to a diagnostic reagent of graft versus host reaction containing the anti-CCL8 antibody.
EFFECT: enabled diagnosis of the beginning of graft versus host reaction and monitoring of progression, particularly differential diagnosis of graft versus host reaction and an infectious disease.
6 cl, 17 dwg, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR GRAFT-VERSUS-HOST REACTION IDENTIFICATION OR TREATMENT | 2012 |
|
RU2632434C2 |
| ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN TRANSPLANTATION AND DISEASE TREATMENT | 2009 |
|
RU2506311C2 |
| ANTI-CD26 ANTIBODIES AND USES THEREOF | 2014 |
|
RU2662933C2 |
| COMBINATION THERAPY FOR STABLE AND LONG TERM ENGRAFTMENT USING SPECIFIC PROTOCOLS FOR T/B-CELL DEPLETION | 2012 |
|
RU2648354C2 |
| GM-CSF OR GM-CSF RECEPTOR LIGANDS FOR USE IN TREATMENT OF HEMOBLASTOSIS IN PATIENT WHO HAS UNDERGONE ALLO-HCT | 2019 |
|
RU2772132C2 |
| METHODS AND COMPOSITIONS FOR IMMUNOMODULATION | 1997 |
|
RU2192281C2 |
| THERAPEUTIC AGENTS AND AUTOIMMUNE DISEASES | 1996 |
|
RU2203088C2 |
| COMBINATION THERAPY FOR STABLE AND LONG-TERM TRANSPLANT ENGRAFTMENT | 2012 |
|
RU2657758C2 |
| BINDING MOLECULES SPECIFIC TO IL-21, AND FIELD OF APPLICATION THEREOF | 2015 |
|
RU2708336C2 |
| NOVEL SOLUBLE POLYPEPTIDES CD83, COMPOSITIONS AND METHODS OF THEIR APPLICATION | 2009 |
|
RU2535340C2 |
